Pages that link to "Q37356697"
Jump to navigation
Jump to search
The following pages link to Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review (Q37356697):
Displaying 50 items.
- Hydroxychloroquine for systemic lupus erythematosus in adults (Q24186197) (← links)
- Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives (Q26774815) (← links)
- Hydroxychloroquine-related retinal toxicity (Q26782822) (← links)
- Inflammatory etiopathogenesis of systemic lupus erythematosus: an update (Q26796413) (← links)
- Chloroquine and hydroxychloroquine for cancer therapy (Q26827797) (← links)
- Juvenile systemic lupus erythematosus: review of clinical features and management (Q26849746) (← links)
- Unmet medical needs in systemic lupus erythematosus (Q27005906) (← links)
- Targeting dendritic cell function during systemic autoimmunity to restore tolerance (Q27687098) (← links)
- Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease (Q28548561) (← links)
- Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis (Q33667694) (← links)
- Management of cardiovascular complications in systemic lupus erythematosus (Q33730536) (← links)
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug (Q33747286) (← links)
- B cell TLRs and induction of immunoglobulin class-switch DNA recombination (Q33893517) (← links)
- Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr Mice (Q33908254) (← links)
- Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression (Q34003992) (← links)
- Ocular Toxicity in Children Exposedin Uteroto Antimalarial Drugs: Review of the Literature (Q34048726) (← links)
- 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DA S28 ESR) (Q34085682) (← links)
- Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus (Q34162739) (← links)
- Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). (Q34169570) (← links)
- Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort (Q34184151) (← links)
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies (Q34187282) (← links)
- Chloroquine cardiomyopathy: beyond ocular adverse effects (Q34198175) (← links)
- Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users. (Q34315879) (← links)
- Chloroquine cardiomyopathy - a review of the literature (Q34342236) (← links)
- Belimumab for the treatment of systemic lupus erythematosus (Q34455827) (← links)
- Systemic lupus erythematosus: review of synthetic drugs (Q34498515) (← links)
- The role of autophagy induced by tumor microenvironment in different cells and stages of cancer (Q35257433) (← links)
- Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies (Q35456519) (← links)
- Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches (Q35621012) (← links)
- Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target (Q35622999) (← links)
- Antiphospholipid Syndrome during pregnancy: the state of the art (Q35756040) (← links)
- Autophagy in autoimmune disease (Q35800364) (← links)
- Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study (Q35840758) (← links)
- Inactive disease and remission in childhood-onset systemic lupus erythematosus (Q35911531) (← links)
- Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? (Q35915182) (← links)
- Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention (Q35998510) (← links)
- Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus (Q36126483) (← links)
- Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry (Q36153524) (← links)
- Metabolic regulation of organelle homeostasis in lupus T cells (Q36177195) (← links)
- Reno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr mice (Q36186103) (← links)
- Macroautophagy is deregulated in murine and human lupus T lymphocytes (Q36194783) (← links)
- Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus (Q36220831) (← links)
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis (Q36221407) (← links)
- Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis (Q36257051) (← links)
- Autophagy regulation in the development and treatment of breast cancer (Q36398762) (← links)
- Contemporary treatment of systemic lupus erythematosus: an update for clinicians. (Q36443689) (← links)
- Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine (Q36672583) (← links)
- Chinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study (Q36869519) (← links)
- Chloroquine interference with hemoglobin endocytic trafficking suppresses adaptive heme and iron homeostasis in macrophages: the paradox of an antimalarial agent (Q36956142) (← links)
- Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus (Q37158591) (← links)